Focused radiation therapy after glioblastoma surgery
Part of Cancer clinical trials.
This trial is testing a new way to deliver radiation therapy to a smaller area of the brain after surgery for glioblastoma. The goal is to see if this more focused approach can treat the tumor effectively while possibly reducing side effects and protecting healthy brain tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have had surgery to remove a glioblastoma brain tumor, and it should be 2 to 6 weeks after the surgery.
- Your overall health should be fairly good, meaning you can manage most daily activities with some help.
- Your blood counts, liver, and kidney function should be within normal ranges.
- You must not have had previous radiation therapy to the head or other cancers.
- You must not be pregnant, breastfeeding, or have serious infections or immune system problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a more focused, stronger dose of radiation can improve outcomes for people 65 and older with newly diagnosed glioblastoma. It compares this approach to standard radiation to see if it's safe and effective.
This trial tests a shorter course of radiation therapy combined with the chemotherapy drug temozolomide for people with glioblastoma, a type of brain cancer. The goal is to see if this approach is effective and safe for patients under 70 who are otherwise in good health.
This trial tests a new type of targeted radiation therapy for people with high-grade glioma (grade 3 or 4) that has not progressed after standard treatment. The therapy uses a radioactive substance attached to a protein that targets tumor cells, aiming to deliver radiation directly to the cancer.
This trial tests a special radiation boost that targets low-oxygen areas of the brain tumor during standard radiation therapy. It may help control the tumor better for people with newly diagnosed or recurrent glioblastoma.
This trial tests a shorter, more intense course of radiation therapy (hypofractionated radiotherapy) for people with newly diagnosed glioblastoma who have had surgery. The goal is to see if this approach is safe and works well for treating the tumor.
This trial tests putting radiation directly into the brain right after surgery for glioblastoma, instead of waiting for standard radiation later. It aims to see if this approach works better and is safe for you.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.